2022
DOI: 10.1016/j.eucr.2022.102015
|View full text |Cite
|
Sign up to set email alerts
|

Adrenal pheochromocytoma in a patient with Lynch Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…In this cohort, one patient presented with Lynch syndrome, which is a non-classic association with only a few cases reported in the literature [31,32]. This suggests that more studies should be done in order to understand the association between these two tumors.…”
Section: Discussionmentioning
confidence: 85%
“…In this cohort, one patient presented with Lynch syndrome, which is a non-classic association with only a few cases reported in the literature [31,32]. This suggests that more studies should be done in order to understand the association between these two tumors.…”
Section: Discussionmentioning
confidence: 85%
“…Unlike the more common and higher-risk genetic mutations in MLH1 and MSH2 , PMS2 has a 3 to 5 times increase in colon and endometrial cancers in people older than 60 years compared to the general population, respectively ( 26 ). In terms of PCCs/PGLs, there have been few reported cases in LS ( 9-13 ). While these mutations of mismatch repair genes can increase the frequency of PCCs/PGLs, it is hard to say whether they have directly contributed or are a coincidence.…”
Section: Discussionmentioning
confidence: 99%
“…It is caused by germline mutations in the mismatch repair genes of MLH1 , MSH2 , MSH6 , PMS2 , and rarely EPCAM , increasing risks for malignancies such as gastrointestinal, genitourinary, brain, and skin ( 8 ). There are very few reported cases of LS presenting with PCCs in the adrenal gland and a case of PGL of the retroperitoneuml ( 9-13 ) (abstract). We present a pregnant patient who has the increased risks of PCCs/PGLs associated with genetic mutations of VHL and LS and discuss the proper management and follow-up plan.…”
Section: Introductionmentioning
confidence: 99%